Status:
UNKNOWN
Dopaminergic Receptors in Sydenham's Chorea
Lead Sponsor:
Shaare Zedek Medical Center
Collaborating Sponsors:
University of Oklahoma
Conditions:
Sydenham Chorea
Strep Throat
Eligibility:
2-40 years
Brief Summary
Sydenham's chorea (SC) is a post-streptococcal, neuropsychiatric disorder associated with anti-neuronal antibodies. The investigators demonstrated elevated anti-D1-receptor (D1R) and anti-D2-receptor ...
Detailed Description
Participants: The investigators will enroll participants with acute Sydenham's chorea (aSC) and age-matched controls with streptococcal tonsillitis (ST) within the past 4 months and healthy children ...
Eligibility Criteria
Inclusion
- sydenham chora OR strep tonsilitiscontrol without strep tonsilitis OR
Exclusion
- neurological disrder autoimmune disorder
Key Trial Info
Start Date :
July 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04084977
Start Date
July 1 2016
End Date
December 30 2021
Last Update
September 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaare Zedek Medical center
Jerusalem, Israel, 91031